CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Goldman Sachs Adjusts Price Target on Amgen to $475 From $450

Positive
AI Analysis

Summary

Goldman Sachs raised its price target on Amgen from $450 to $475 per share, reflecting increased analyst confidence in the company.

Importance:2/10
Sentiment:
0.30
price_targetanalyst_update
Related Companies

Read the original article

Published by yahoo_finance on October 13, 2026 9:44 AM

Read Original